Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes [Yahoo! Finance]
Bausch + Lomb Corporation (BLCO)
Company Research
Source: Yahoo! Finance
VAUGHAN, Ontario, April 25, 2024 BUSINESS WIRE )--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Frontiers in Ophthalmology published statistically significant results from a clinical study evaluating the efficacy and safety of a novel daily nutritional supplement formulated to address the symptoms of dry eyes. Bausch + Lomb expects to launch the supplement, which features a proprietary blend of ingredients including lutein, zeaxanthin isomers, curcumin and vitamin D3, under the brand name Blink™ NutriTears ® early in the third quarter of 2024 in the U.S. The clinical study met both primary endpoints: Change from baseline at day 56 (week eight) in tear production (Schirmer's test). Change from baseline at day 56 in ocular symptoms measured by OSDI score. The study also met secondary endpoints, showing statistically significant improvements in tear-film break-up time (TBUT),
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall [Yahoo! Finance]Yahoo! Finance
- Why Bausch Health Companies Stock Dived by More Than 7% Today [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Co. (NYSE: BLCO) had its price target lowered by analysts at Evercore Inc. from $17.00 to $15.00. They now have an "in-line" rating on the stock.MarketBeat
- Number of voting rights as of April 30, 2024 [Yahoo! Finance]Yahoo! Finance
BLCO
Earnings
- 5/1/24 - Miss
BLCO
Sec Filings
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 4/29/24 - Form ARS
- BLCO's page on the SEC website